Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis
Mark McPhail, Debbie L. Shawcross, Matthew R. Lewis, et al.
Journal of Hepatology (2016) Vol. 64, Iss. 5, pp. 1058-1067
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis
Gabriel Mezzano, Adrià Juanola, Andrés Cárdenas, et al.
Gut (2021) Vol. 71, Iss. 1, pp. 148-155
Closed Access | Times Cited: 141
Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial
Vishal Patel, Sunjae Lee, Mark McPhail, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 2, pp. 332-342
Open Access | Times Cited: 139
Acute-on-chronic liver failure in patients with alcohol-related liver disease
Thierry Gustot, Rajiv Jalan
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 319-327
Open Access | Times Cited: 131
Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis
Jasmohan S. Bajaj, K. Rajender Reddy, Jacqueline G. O’Leary, et al.
Gastroenterology (2020) Vol. 159, Iss. 5, pp. 1715-1730.e12
Open Access | Times Cited: 88
PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF
Jiang Li, Xi Liang, Jing Jiang, et al.
Gut (2021) Vol. 71, Iss. 1, pp. 163-175
Open Access | Times Cited: 85
Acute-on-chronic liver failure: far to go—a review
Jinjin Luo, Jiaqi Li, Peng Li, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Baicalin and N-acetylcysteine regulate choline metabolism via TFAM to attenuate cadmium-induced liver fibrosis
Jian Sun, Yan Chen, Tao Wang, et al.
Phytomedicine (2024) Vol. 125, pp. 155337-155337
Closed Access | Times Cited: 12
Definitions, Etiologies, and Outcomes of Acute on Chronic Liver Failure: A Systematic Review and Meta-analysis
Arnav Aggarwal, Sagnik Biswas, Umang Arora, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 11, pp. 2199-2210.e25
Closed Access | Times Cited: 11
The decreasing predictive power of MELD in an era of changing etiology of liver disease
Elizabeth L. Godfrey, Tahir H. Malik, Jennifer C. Lai, et al.
American Journal of Transplantation (2019) Vol. 19, Iss. 12, pp. 3299-3307
Open Access | Times Cited: 70
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
Diren Beyoğlu, Jeffrey R. Idle
Metabolites (2020) Vol. 10, Iss. 2, pp. 50-50
Open Access | Times Cited: 68
Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma
Christa Buechler, Charalampos Aslanidis
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2020) Vol. 1865, Iss. 5, pp. 158658-158658
Closed Access | Times Cited: 67
Chronic Liver Diseases and the Microbiome—Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease
Chathur Acharya, Jasmohan S. Bajaj
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 556-572
Open Access | Times Cited: 64
Metabonomics Research Progress on Liver Diseases
Mengqian Yu, Ying Zhu, Qingwei Cong, et al.
Canadian Journal of Gastroenterology and Hepatology (2017) Vol. 2017, pp. 1-10
Open Access | Times Cited: 62
Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis
J. J. Clariá, Anna Curto, Richard Moreau, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 5, pp. 1116-1127
Open Access | Times Cited: 40
Lysophosphatidylcholines modulate immunoregulatory checkpoints in peripheral monocytes and are associated with mortality in people with acute liver failure
Francesca M. Trovato, Rabiya Zia, Florent Artru, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 558-573
Open Access | Times Cited: 31
Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis
Ayse L. Mindikoglu, Antone R. Opekun, Nagireddy Putluri, et al.
Translational research (2017) Vol. 195, pp. 25-47
Open Access | Times Cited: 56
From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine
Jeremy R. Everett
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 54
1H NMR-based metabolite profiling for biomarker identification
Ruan A. Silva, Tayla C. S. Pereira, Alzenir R. Souza, et al.
Clinica Chimica Acta (2019) Vol. 502, pp. 269-279
Closed Access | Times Cited: 43
Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis
Jasmohan S. Bajaj, Guadalupe García‐Tsao, K. Rajender Reddy, et al.
Hepatology (2021) Vol. 74, Iss. 5, pp. 2699-2713
Open Access | Times Cited: 39
Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute‐on‐Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid–Dependent Monocyte Activation
Francesca M. Trovato, Rabiya Zia, Salvatore Napoli, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 907-925
Open Access | Times Cited: 38
Cirrhosis and Faecal microbiota Transplantation (ChiFT) protocol: a Danish multicentre, randomised, placebo-controlled trial in patients with decompensated liver cirrhosis
Sidsel Støy, Lotte Lindgreen Eriksen, Johanne Sloth Lauszus, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e091078-e091078
Open Access
Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction
Samantha Lodge, Nathan G. Lawler, Nicola Gray, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11614-11614
Open Access | Times Cited: 11
Comparative metabolome analysis reveals higher potential of haemoperfusion adsorption in providing favourable outcome in ACLF patients
Manisha Yadav, Rakhi Maiwal, Vinay Kumar BR, et al.
Liver International (2024) Vol. 44, Iss. 5, pp. 1189-1201
Closed Access | Times Cited: 3
Application of NMR metabolomics to search for human disease biomarkers in blood
Zikuan Song, Haoyu Wang, Xiaotong Yin, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2018) Vol. 57, Iss. 4, pp. 417-441
Open Access | Times Cited: 37
Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis Cohort
Jasmohan S. Bajaj, Puneeta Tandon, Jacqueline G. O’Leary, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 4, pp. 1031-1040.e3
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top